NCT06183970

Brief Summary

To investigate the impact of algorithms utilizing artificial intelligence technology and computer vision on the recovery of motor functions within the context of rehabilitation practice for patients who have experienced a cerebral stroke.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Feb 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 28, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

December 28, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

August 24, 2023

Last Update Submit

December 26, 2023

Conditions

Keywords

RehabilitationArtificial intelligenceComputer visionMotion captureAssistive technology

Outcome Measures

Primary Outcomes (3)

  • Fugl-Meyer Assessment Scale for upper extremity assessment (FMA-UE)

    In this study, we wiil use 36 items of the upper arm (proximal musculature, FMA-UA), 24 items of wrist and hand (distal musculature, FMA-W/H), 6 items of aspects of coordination, 12 items of aspects of sensation, 24 items of aspects of passive joint movement, 24 items of joint pain. So the maximum total score on this FMA-UE scale was 126 points.

    Change from baseline at 3 weeks

  • Muscle strength was assessed using the MRC (Medical Research Council Weakness Scale)

    MRC is a commonly used scale for assessing muscle strength from Grade 5 (normal) to Grade 0 (no visible contraction). Paresis is defined as light at compliance with strength 4 points, moderate - 3 points, pronounced - 2 points, rough - 1 point and with - 0 points.

    Change from baseline at 3 weeks

  • The Action Research Arm Test (ARAT)

    Is a 19 item observational measure used by physical therapists and other health care professionals to assess upper extremity performance (coordination, dexterity and functioning) in stroke recovery, brain injury and multiple sclerosis populations. Scores on the ARAT may range from 0-57 points, with a maximum score of 57 points indicating better performance. MCID has been suggested as 5.7 points

    Change from baseline at 3 weeks

Secondary Outcomes (6)

  • The speed of movement of the upper limb

    Change from baseline at 3 weeks

  • Accuracy of performed movements

    Change from baseline at 3 weeks

  • Total number of repetitions

    Change from baseline at 3 weeks

  • The correctness of the exercises

    Change from baseline at 3 weeks

  • The number of exercises completed

    Change from baseline at 3 weeks

  • +1 more secondary outcomes

Study Arms (3)

AssistI patients

EXPERIMENTAL

Patients will receive rehabilitation training using the AsistI software package in conjunction with standard upper limb rehabilitation interventions.

Device: AssistI patients

Habilect patients

ACTIVE COMPARATOR

Patients will receive rehabilitation training using the Habilect software and hardware complex, in addition to standard rehabilitation interventions for the upper limb.

Device: Habilect patients

Conventional therapy patients

NO INTERVENTION

Patients will undergo standard upper limb rehabilitation interventions without the utilization of additional methods.

Interventions

The AsistI software package rehabilitation involves tailored upper limb exercises under an individual program. The regimen consists of 10-12 sessions, each lasting 30 minutes. Patients execute 10 exercises sequentially with their unaffected and affected limbs, involving tasks like touching mouth, forehead, and trunk parts with hand's brush, and amplitude movements in upper limb joints. AsistI assesses exercise accuracy, prevents unfavorable patterns, and logs target achievement, considering speed, accuracy, and repetitions.

AssistI patients

The Habilect rehab program involves 10-12 sessions using software and hardware. Patients perform upper limb exercises for 30 minutes individually, focusing on specific movements. They repeat 10 exercises, first with the healthy limb, then the affected one. Tasks include touching mouth, forehead, and trunk, along with joint movements like shoulder flexion. Habilect assesses exercise accuracy, preventing wrong moves, and tracks progress, considering speed, accuracy, repetitions.

Habilect patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Recent hemispheric stroke (ischemic or hemorrhagic):
  • Rankin scale: 3
  • Within 6 months post stroke.
  • Upper limb hemiparesis with strength ≤3 points proximally.
  • Muscle tone rise (≤3 points) on Ashford scale.
  • Complex sensitivity preserved per neuro examination

You may not qualify if:

  • Rankin scale of 4 points and higher.
  • months or more after undergoing stroke.
  • Structural changes in the joints of the upper extremities that limit joint mobility (contractures, ankylosis, metal structures that limit mobility).
  • Severe pain syndrome in the paretic upper limb at rest or when moving, preventing exercise (7 points or more on the scale).
  • Gross cognitive disorders, psychoemotional arousal, signs of hysteria, pseudobulbar syndrome (violent laughter, crying), aphasic disorders that prevent understanding of the task.
  • Visual disturbances that prevent the perception of information (neglect, hemianopia, myopia, diplopia).
  • Thrombosis of the veins in the upper and lower extremities without signs of recanalization, or arterial thrombosis.
  • Parkinsonism and other types of tremor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokeParesisCerebellar Ataxia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCerebellar DiseasesAtaxiaDyskinesias

Study Officials

  • Michael Gorodnichev

    Moscow Technical University of Communication and Informatics (MTUCI)

    STUDY CHAIR
  • Galina Ivanova, Prof

    Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2023

First Posted

December 28, 2023

Study Start

February 1, 2024

Primary Completion

August 1, 2024

Study Completion

February 1, 2025

Last Updated

December 28, 2023

Record last verified: 2023-08